You’re invited to join Eurofins PFAS expert, Leonard Harris, for a live question and answer session addressing your most pressing medical device PFAS questions. This interactive session will explore key topics while providing clarity and practical insights to help you navigate the PFAS landscape.

During this session, Mr. Harris will provide insights into the following:

• Current and upcoming PFAS regulations
• Risk management
• Material alternatives
• Supply chain implications
• Future insights for device PFAS

	Leonard Harris Senior Scientific Advisor Eurofins Medical Device Services
As a Senior Scientific Advisor at Eurofins Medical Device Services, Mr. Harris evaluates new technology and testing techniques for the medical device industry. This includes keeping abreast of industry trends as well as working to determine the impact of changes in regulations on the industry. With 25 years of industry experience in pharmaceuticals and medical device chemical testing, Mr. Harris is experienced in GMP and ISO test methods and validations, investigations, protocol validations, and data analysis. Mr. Harris holds a B.S. degree in chemistry from Shippensburg University.
	Kimberly Ehman, PhD, DABT (Moderator) Head of Regulatory Toxicology Eurofins Medical Device Services
As Head of Regulatory Toxicology, Kimberly Ehman leads the biocompatibility consulting and toxicological risk assessment services for Eurofins Medical Device Services North America. She has more than 20 years of toxicology and medical device experience, with expertise in toxicological risk assessments for medical devices, food and beverage products, and electronic nicotine delivery systems. Prior to joining Eurofins, she was the Director of Regulatory Toxicology and Consulting at WuXi AppTec and has also held positions at Altria Client Services (Head of Regulatory Toxicology), Toxicology Regulatory Services (Consulting Toxicologist and Program Manager), and RTI International (Research Toxicologist for Developmental and Reproductive Toxicology and Neurotoxicology). She earned her PhD from McGill University in Montréal, Canada, and conducted her postdoctoral research at the US EPA, with a focus on developmental neurotoxicology. She has been a Diplomate of the American Board of Toxicology since 2009 and an active member of the Society of Toxicology (SOT) since 2005 and the American College of Toxicology (ACT) since 2010. She is currently the VP-elect for the Medical Device and Combination Product Specialty Section (MDCPSS) of SOT and serves as an expert on several US working groups for the ISO 10993 series of standards, including ISO 10993-1 (Evaluation and testing within a risk management process), ISO 10993-3 (Tests for genotoxicity, carcinogenicity, and reproductive toxicity), and ISO 10993-17 (Toxicological risk assessment of medical device constituents).